Gabapentin in patients with the pruritus of cholestasis: A double-blind, randomized, placebo-controlled trial

Hepatology

Volumn 44, Issue 5, 2006, Pages 1317-1323

  Bergasa, Nora V ^a   McGee, Monnie ^b   Ginsburg, Iona H ^c   Engler, Danielle ^c  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b SOUTHERN METHODIST UNIVERSITY   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; COLESTYRAMINE; CREATININE; GABAPENTIN; NALTREXONE; ONDANSETRON; PLACEBO; RIFAMPICIN; SERTRALINE; URSODEOXYCHOLIC ACID;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ARTICLE; CARPAL TUNNEL SYNDROME; CHOLESTASIS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; FATIGUE; FEMALE; HOSPITAL PATIENT; HUMAN; INTERVIEW; LIVER TRANSPLANTATION; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCRATCHING; VISUAL ANALOG SCALE; VOMITING;

ADULT; AMINES; ANALGESICS; CHOLESTASIS; CHRONIC DISEASE; CYCLOHEXANECARBOXYLIC ACIDS; DOUBLE-BLIND METHOD; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; LIVER DISEASES; MIDDLE AGED; PAIN MEASUREMENT; PRURITUS;

EID: 33750993501     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21370     Document Type: Article

References (34)

1. Jones EA, Bergasa NV. The pruritus of cholestasis. HEPATOLOGY 1999;29:1003-1006.
2. Bergasa NV. The pruritus of cholestasis. J Hepatol 2005;43:1078-1088.
3. Magerl W. Neural mechanisms of itch sensation. IASP Newsletter 1996;Sept-Oct.
4. Gustafsson H, Flood K, Berge OG, Brodin E, Olgart L, Stiller CO. Gabapentin reverses mechanical allodynia induced by sciatic nerve ischemia and formalin-induced nociception in mice. Exp Neurol 2003;182:427-434.
5. Rodrigues-Filho R, Campos MM, Ferreira J, Santos AR, Bertelli JA, Calixto JB. Pharmacological characterisation of the rat brachial plexus avulsion model of neuropathic pain. Brain Res 2004;1018(2):159-170.
6. Bueller HA, Bernhard JD, Dubroff LM. Gabapentin treatment for brachioradial pruritus. J Eur Acad Dermatol Venereol 1999;13:227-228.
7. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatr 1960;23:56-62.
8. Williams JB, Gibbon M, First MB, Spitzer RL, Davies M, Borus J, et al. The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Arch Gen Psychiatry 1992;49:630-636.
9. Bergasa NV, Talbot TL, Alling DW, Schmitt JM, Walker EC, Baker BL, et al. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology 1992;102:544-549.
10. Bergasa NV, Talbot TL, Schmitt JP, Alling DW, Swain MG, Turner M, et al. Open label trial of oral nalmefene therapy for the pruritus of cholestasis. HEPATOLOGY 1998;27:679-684.
11. Bergasa NV, Alling DW, Talbot TL, Swain MG, Yurdaydin C, Schmitt JM, et al. Naloxone ameliorates the pruritus of cholestasis: results of a double-blind randomized placebo-controlled trial. Ann Intern Med 1995;123:161-167.
12. Bergasa NV, Alling DW, Talbot TL, Wells M, Jones EA. Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study. J Am Acad Dermatol 1999;41:431-434.
13. Talbot TL, Schmitt JM, Bergasa NV, Jones EA, Walker EC. Application of piezo film technology for the quantitative assessment of pruritus. Biomed Instrum Technol 1991;25:400-403.
14. Little R, Rubin D. Statistical Analysis with Missing Data. 2nd ed. New York: Wiley Interscience, 2002.
15. McGee M, Bergasa NV. Imputing Missing Data in Clinical Pilot Studies. Technical Report. Dallas, TX: Southern Methodist University, 2005.
16. Kradin RL. The placebo response: its putative role as a functional salutogenic mechanism of the central nervous system. Perspect Biol Med 2004;47:328-338.
17. de la Fuente-Fernandez R, Ruth TJ, Sossi V, Schulzer M, Calne DB, Stoessl AJ. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 2001;293:1164-1166.
18. Carson KL, Tran TT, Cotton P, Sharara AI, Hunt CM. Pilot study of the use of naltrexone to treat the severe pruritus of cholestatic liver disease. Am J Gastroenterol 1996;91:1022-1023.
19. Wolfhagen FHJ, Sternieri E, Hop WCJ, Vitale G, Bertolotti M, van Buuren HR. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study. Gastroenterology 1997;113:1264-1269.
20. Neuberger J, Jones EA. Liver transplantation for intractable pruritus is contraindicated before an adequate trial of opiate antagonist therapy. Eur J Gastroenterol Hepatol 2001;13:1393-1394.
21. Terg R, Coronel E, Sorda J, Munoz AE, Findor J. Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study. J Hepatol 2002;37:717-722.
22. Horta ML, Ramos L, Goncalves ZR. The inhibition of epidural morphine-induced pruritus by epidural droperidol. Anesth Analg 2000;90:638-641.
23. Horta ML, Ramos L, Goncalves Zda R, de Oliveira MA, Tonellotto D, Teixeira JP, et al. Inhibition of epidural morphine-induced pruritus by intravenous droperidol. The effect of increasing the doses of morphine and of droperidol. Reg Anesth 1996;21:312-317.
24. Baldessarini RJ. Drugs and the treatment of psychiatric disorders. In: Molinoff PB, Ruddon RW, eds. The Pharmacological Basis of Therapeutics. New York: McGraw-Hill, 1996:399-430.
25. Coté L, Crutcher M. The basal ganglia. In: Kandel ER, Scwartz JH, Jessell TM, eds. Principles of Neural Science. Norwalk: Appleton and Lange, 1991:647-659.
26. McFarland NR, Haber SN. Thalamic relay nuclei of the basal ganglia form both reciprocal and nonreciprocal cortical connections, linking multiple frontal cortical areas. J Neurosci 2002;22:8117-8132.
27. Hsieh JC, Hagermark O, Stahle-Backdahl M, Ericson K, Eriksson L, Stone-Elander S, et al. Urge to scratch represented in the human cerebral cortex during itch. J Neurophysiol 1994;72:3004-3008.
28. Drzezga A, Darsow U, Treede RD, Siebner H, Frisch M, Munz F, et al. Central activation by histamine-induced itch: analogies to pain processing: a correlational analysis of O-15 H2O positron emission tomography studies. Pain 2001;92(1-2):295-305.
29. Mochizuki H, Tashiro M, Kano M, Sakurada Y, Itoh M, Yanai K. Imaging of central itch modulation in the human brain using positron emission tomography. Pain 2003;105(1-2):339-346.
30. Reimann W. Inhibition by GABA, baclofen and gabapentin of dopamine release from rabbit caudate nucleus: are there common or different sites of action? Eur J Pharmacol 1983;94:341-344.
31. Andrews N, Loomis S, Blake R, Ferrigan L, Singh L, McKnight AT. Effect of gabapentin-like compounds on development and maintenance of morphine-induced conditioned place preference. Psychopharmacology (Berl) 2001;157:381-387.
32. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 2004;303:1162-1167.
33. Elias E. Liver Transplantation. J Roy Coll Phys London 1993;27:224-232.
34. Jones EA, Neuberger J, Bergasa NV. Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions. QJM 2002;95:547-552.